While humans and rodents may experience hepatitis and MB formation following griseofulvin treatment, severe hepatitis is more common in rodents due to the stronger binding affinity of griseofulvin to K18 in rodents compared to humans [16]. This evidence concerns the gene KRT18 and hepatitis A virus infection.